Feeding: How specific molecules can lead to overeating
Toasted marshmallows, roasted nuts and fried potatoes are just a few examples of foods that owe their unique taste to a chemical reaction that produces molecules called advanced glycation end-products. These compounds form when sugars react spontaneously with proteins or lipids without the involvement of enzymes. Modern processed foods, especially those subjected to high temperatures for long periods of time – as happens with grilling, roasting or frying – are particularly high in advanced glycation end-products (Liu et al., 2020), but these compounds can also be produced in the body during metabolic processes (Reddy et al., 2022).
Advanced glycation end-products (AGEs) have been linked to several medical conditions, particularly diabetes, where they contribute to tissue damage and inflammation (Ramasamy et al., 2005). More recent research suggests that they can also increase neuronal damage and reduce the life span of roundworms (Chaudhuri et al., 2016). Now, in eLife, Pankaj Kapahi and colleagues based at various research institutes in the United States – including Muniesh Muthaiyan Shanmugam (Buck Institute for Research on Aging) as first author – report on the intriguing connection between diet, molecular signaling, feeding behavior and neurodegeneration in the roundworm C. elegans (Muthaiyan Shanmugam et al., 2023).
Shanmugam et al. compared the food intake of healthy worms and knock-out worms that lacked an enzyme called GLOD-4, which is responsible for degrading a compound known as methylglyoxal, a precursor of many AGE compounds (Chaudhuri et al., 2016). The high level of AGE compounds in the knock-out worms appeared to increase their food intake (as indicated by a high pharyngeal pumping rate). Consuming the AGE compound hydroimidazolone also caused the healthy worms to eat more. This suggests that the relationship between the accumulation of AGE compounds and over-eating could be conserved across the animal kingdom.
The experiments also showed that the response to AGE compounds is gradual, not immediate, with a pronounced increase in food intake occurring 24 hours after the introduction of hydroimidazolone. This temporal dimension makes it more difficult to understand how dietary choices impact feeding behavior over time. RNA sequencing also revealed that genes that code for neurotransmitters, and genes that code for proteins regulating feeding behavior, were upregulated in the knock-out worms.
Previous research has shown that biogenic amines – biomolecules that contain one or more amine groups – play a role in feeding behavior throughout the animal kingdom (Greer et al., 2008). Given this, and the differential expression of genes observed in the knock-out worms, Shanmugam et al. investigated how mutations in genes related to the synthesis of amines affected food intake in worms exposed to hydroimidazolone. They found that mutations in an enzyme called TDC-1 – which is responsible for synthesizing the amine tyramine, the invertebrate equivalent of adrenaline – stopped the overfeeding that is usually induced by hydroimidazolone.
Moreover, glod-4 mutant animals without tyramine had decreased damage in their nervous system and longer lifespans. This suggests that tyramine is a key regulator of overeating induced by hydroimidazolone, but more research is needed to fully understand the role of this particular amine. The negative effects of AGE compounds in the knock-out worms could be due to excessive eating triggered by tyramine, or it might be that tyramine itself is causing damage, as noted in a previous study (De Rosa et al., 2019). Additionally, two G-protein-coupled receptors that respond to tyramine were also implicated in the process.
The study also unravels a critical aspect of how AGE compounds influence feeding behavior at a molecular level. Specifically, exposure to hydroimidazolone increases the transcription of the gene that codes for the enzyme TDC-1, and this upregulation relies on the presence of a transcription factor called ELT-3 (Figure 1). This finding enriches our understanding of the mechanisms through which AGE compounds impact feeding behavior.
![](https://iiif.elifesciences.org/lax:93090%2Felife-93090-fig1-v1.tif/full/617,/0/default.jpg)
The relationship between AGE compounds and food intake.
Advanced glycation end-products (AGEs) can accumulate due to dietary intake (top left) or due to a lack of enzymes that break down their precursors (bottom left). This accumulation leads to the build-up of an AGE compound called hydroimidazolone (MG-H1), which stimulates the overexpression of tyramine through the ELT-2/GATA transcription factor pathway (top middle). The upregulation of tyramine promotes increased food intake, which, in turn, further increases the amount of hydroimidazolone in the body. This positive feedback loop, mediated by AGE compounds, ultimately reduces the lifespan of C. elegans (top right), and also accelerates neurodegeneration (bottom right).
It is becoming increasingly evident that AGE compounds actively participate in the regulation of physiological functions, rather than being passive byproducts of metabolic processes. The work of Shanmugam et al. demonstrates that, in C. elegans at least, overeating due to an accumulation of AGE compounds depends on the modulation of biogenic amine signals. This knowledge could contribute to a better understanding of a range of systemic diseases, including diabetes, obesity and various neurodegenerative disorders.
Shanmugam et al. also highlight the evolutionary importance of these processes. The changes to tyramine signaling responsible for the detrimental effects of AGE compounds in C. elegans raise the tantalizing possibility that aminergic modulation may have similar effects in humans. For example, prolonged adrenaline release in humans due to chronic stress has been associated with obesity, diabetes and premature aging (Yiallouris et al., 2019).
The work of Shanmugam et al. offers valuable insights into the interplay between dietary choices, molecular signaling and health. By unveiling a new pathway involving AGE compounds and aminergic signaling in C. elegans, this research enriches our understanding of the regulation of feeding behavior. It also encourages a re-evaluation of the impact of dietary AGE compounds on human health and motivates further exploration of their potential role in the development of chronic diseases.
References
-
Adrenal aging and its implications on stress responsiveness in humansFrontiers in Endocrinology 10:54.https://doi.org/10.3389/fendo.2019.00054
Article and author information
Author details
Publication history
Copyright
© 2023, Blanco and Rayes
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 867
- views
-
- 65
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Epidemiology and Global Health
- Genetics and Genomics
Background:
Maternal smoking has been linked to adverse health outcomes in newborns but the extent to which it impacts newborn health has not been quantified through an aggregated cord blood DNA methylation (DNAm) score. Here, we examine the feasibility of using cord blood DNAm scores leveraging large external studies as discovery samples to capture the epigenetic signature of maternal smoking and its influence on newborns in White European and South Asian populations.
Methods:
We first examined the association between individual CpGs and cigarette smoking during pregnancy, and smoking exposure in two White European birth cohorts (n=744). Leveraging established CpGs for maternal smoking, we constructed a cord blood epigenetic score of maternal smoking that was validated in one of the European-origin cohorts (n=347). This score was then tested for association with smoking status, secondary smoking exposure during pregnancy, and health outcomes in offspring measured after birth in an independent White European (n=397) and a South Asian birth cohort (n=504).
Results:
Several previously reported genes for maternal smoking were supported, with the strongest and most consistent association signal from the GFI1 gene (6 CpGs with p<5 × 10-5). The epigenetic maternal smoking score was strongly associated with smoking status during pregnancy (OR = 1.09 [1.07, 1.10], p=5.5 × 10-33) and more hours of self-reported smoking exposure per week (1.93 [1.27, 2.58], p=7.8 × 10-9) in White Europeans. However, it was not associated with self-reported exposure (p>0.05) among South Asians, likely due to a lack of smoking in this group. The same score was consistently associated with a smaller birth size (–0.37±0.12 cm, p=0.0023) in the South Asian cohort and a lower birth weight (–0.043±0.013 kg, p=0.0011) in the combined cohorts.
Conclusions:
This cord blood epigenetic score can help identify babies exposed to maternal smoking and assess its long-term impact on growth. Notably, these results indicate a consistent association between the DNAm signature of maternal smoking and a small body size and low birth weight in newborns, in both White European mothers who exhibited some amount of smoking and in South Asian mothers who themselves were not active smokers.
Funding:
This study was funded by the Canadian Institutes of Health Research Metabolomics Team Grant: MWG-146332.
-
- Cancer Biology
- Genetics and Genomics
It takes more than 20 years for normal colorectal mucosa to develop into metastatic carcinoma. The long time window provides a golden opportunity for early detection to terminate the malignant progression. Here, we aim to enable liquid biopsy of T1a stage colorectal cancer (CRC) and precancerous advanced adenoma (AA) by profiling circulating small extracellular vesicle (sEV)-derived RNAs. We exhibited a full RNA landscape for the circulating sEVs isolated from 60 participants. A total of 58,333 annotated RNAs were detected from plasma sEVs, among which 1,615 and 888 sEV-RNAs were found differentially expressed in plasma from T1a stage CRC and AA compared to normal controls (NC). Then we further categorized these sEV-RNAs into six modules by a weighted gene coexpression network analysis and constructed a 60-gene t-SNE model consisting of the top 10 RNAs of each module that could well distinguish T1a stage CRC/AA from NC samples. Some sEV-RNAs were also identified as indicators of specific endoscopic and morphological features of different colorectal lesions. The top-ranked biomarkers were further verified by RT-qPCR, proving that these candidate sEV-RNAs successfully identified T1a stage CRC/AA from NC in another cohort of 124 participants. Finally, we adopted different algorithms to improve the performance of RT-qPCR-based models and successfully constructed an optimized classifier with 79.3% specificity and 99.0% sensitivity. In conclusion, circulating sEVs of T1a stage CRC and AA patients have distinct RNA profiles, which successfully enable the detection of both T1a stage CRC and AA via liquid biopsy.